Wordt geladen...
Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes
Dipeptidyl peptidase-4 (DPP-4) inhibitors have recently emerged as a new class of antidiabetic that show favorable results in improving glycemic control with a minimal risk of hypoglycemia and weight gain. Teneligliptin, a novel DPP-4 inhibitor, exhibits a unique structure characterized by five cons...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3650886/ https://ncbi.nlm.nih.gov/pubmed/23671395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S35682 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|